Literature DB >> 21610505

Tracer kinetic model selection for dynamic contrast-enhanced computed tomography imaging of prostate cancer.

Johannes G Korporaal1, Marco van Vulpen, Cornelis A T van den Berg, Uulke A van der Heide.   

Abstract

OBJECTIVES: To investigate the conditions under which the Tofts, extended Tofts, and adiabatic approximation to the tissue homogeneity (AATH) model are the optimal tracer kinetic models (TKMs) for the quantification of dynamic contrast-enhanced (DCE) computed tomography (CT) examinations in prostate cancer.
MATERIALS AND METHODS: This prospective study was approved by the local research ethics committee, and all patients gave written informed consent. A total of 29 patients (mean age, 69.1 years; range, 56-80 years) with biopsy-proven prostate cancer underwent a DCE-CT examination prior to radiation therapy. TKM parameter maps were calculated for each patient with the Tofts, extended Tofts, and AATH models. For each voxel, corrected Akaike information criterion values were calculated, taking into account both the goodness-of-fit and the number of model parameters. We consider the optimal model as the model with the lowest corrected Akaike information criterion.
RESULTS: All 3 TKMs are the optimal models in part of the prostate. For individual patients, the AATH model was the optimal model in 25.0% to 88.9%, the Tofts in 2.7% to 71.8%, and the extended Tofts model in 0.7% to 68.7% of the prostate voxels. The Tofts model was optimal in low flow regions (<0.1 min-1), the extended Tofts model in regions with high flow (>0.4 min-1) and low transit time (<12 seconds), and the AATH model in the intermediate flow range (0.1-0.4 min-1). However, differences between the 3 models were small and TKM parameter estimates gave consistent results between the 3 models.
CONCLUSIONS: All the 3 models gave reasonable fits of DCE-CT data from the prostate. In view of the small parameter range in which the Tofts and extended Tofts models outperform the AATH model, the latter seems the optimal model for quantification of DCE-CT data of the prostate.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21610505     DOI: 10.1097/RLI.0b013e31821c0ea7

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  7 in total

1.  Assessment of prostate cancer with integrated CT-perfusion using a sector-wise approach.

Authors:  Matteo Ferrari; Martin Huellner; Chantal Pauli; Burkhardt Seifert; Hansjörg Danuser; Patrick Veit-Haibach; Agostino Mattei
Journal:  Turk J Urol       Date:  2017-05-03

Review 2.  Tracer-kinetic modeling of dynamic contrast-enhanced MRI and CT: a primer.

Authors:  Michael Ingrisch; Steven Sourbron
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-04-06       Impact factor: 2.745

3.  Arterial input function calculation in dynamic contrast-enhanced MRI: an in vivo validation study using co-registered contrast-enhanced ultrasound imaging.

Authors:  Hatef Mehrabian; Chaitanya Chandrana; Ian Pang; Rajiv Chopra; Anne L Martel
Journal:  Eur Radiol       Date:  2012-03-27       Impact factor: 5.315

4.  Quantitative graphical analysis of simultaneous dynamic PET/MRI for assessment of prostate cancer.

Authors:  Andrew B Rosenkrantz; Thomas Koesters; Anne-Kristin Vahle; Kent Friedman; Rachel M Bartlett; Samir S Taneja; Yu-Shin Ding; Jean Logan
Journal:  Clin Nucl Med       Date:  2015-04       Impact factor: 7.794

5.  Characterization of tumor heterogeneity using dynamic contrast enhanced CT and FDG-PET in non-small cell lung cancer.

Authors:  P Veit-Haibach; D De Ruysscher; W van Elmpt; M Das; Martin Hüllner; H Sharifi; K Zegers; B Reymen; P Lambin; J E Wildberger; E G C Troost
Journal:  Radiother Oncol       Date:  2013-09-14       Impact factor: 6.280

6.  Comparison of linear and nonlinear implementation of the compartmental tissue uptake model for dynamic contrast-enhanced MRI.

Authors:  Jesper F Kallehauge; Steven Sourbron; Benjamin Irving; Kari Tanderup; Julia A Schnabel; Michael A Chappell
Journal:  Magn Reson Med       Date:  2016-09-08       Impact factor: 4.668

7.  4D perfusion CT of prostate cancer for image-guided radiotherapy planning: A proof of concept study.

Authors:  Lucian Beer; Stephan H Polanec; Pascal A T Baltzer; Georg Schatzl; Dietmar Georg; Christian Schestak; Anja Dutschke; Harald Herrmann; Peter Mazal; Alexander K Brendel; Shahrokh F Shariat; Helmut Ringl; Thomas H Helbich; Paul Apfaltrer
Journal:  PLoS One       Date:  2019-12-19       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.